Showing 169 to 171 of 171 results


Stanley Tucci's Wife Details His "Horrific" Oral Cancer Treatment
Felicity Blunt shared details about Stanley Tucci's 2017 oral cancer battle, revealing six rounds of chemotherapy, a six-month feeding tube, and the loss of taste and ability to eat, highlighting the devastating impact on their lives.
Stanley Tucci's Wife Details His "Horrific" Oral Cancer Treatment
Felicity Blunt shared details about Stanley Tucci's 2017 oral cancer battle, revealing six rounds of chemotherapy, a six-month feeding tube, and the loss of taste and ability to eat, highlighting the devastating impact on their lives.
Progress
44% Bias Score


Gamaleya Institute's mRNA Cancer Vaccine Shows Promise in Preclinical Trials
Preclinical trials of Gamaleya Research Institute's mRNA melanoma vaccine show tumor and metastasis regression in animals; human trials are planned for autumn 2025, initially combining the vaccine with other therapies for advanced cancers; future development aims for personalized, affordable vaccine...
Gamaleya Institute's mRNA Cancer Vaccine Shows Promise in Preclinical Trials
Preclinical trials of Gamaleya Research Institute's mRNA melanoma vaccine show tumor and metastasis regression in animals; human trials are planned for autumn 2025, initially combining the vaccine with other therapies for advanced cancers; future development aims for personalized, affordable vaccine...
Progress
56% Bias Score

NHS Approves New Drug for Uveal Melanoma, Boosting Survival Rates
The NHS will offer tebentafusp, a new drug for uveal melanoma, to hundreds of patients in England, increasing three-year survival rates by 9% compared to current treatments, offering a significant improvement for this rare and difficult-to-treat cancer.

NHS Approves New Drug for Uveal Melanoma, Boosting Survival Rates
The NHS will offer tebentafusp, a new drug for uveal melanoma, to hundreds of patients in England, increasing three-year survival rates by 9% compared to current treatments, offering a significant improvement for this rare and difficult-to-treat cancer.
Progress
40% Bias Score
Showing 169 to 171 of 171 results